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Background: Ring chromosome 18 [r(18)] is formed by 18p- and 18q- partial deletion and generates a ring chromosome.
Loss of critical genes on each arm of chromosome 18 may contribute to the specific phenotype, and the clinical spectrum
varieties may heavily depend on the extent of the genomic deletion. The aim of this study is to identify the detailed
breakpoints location and the deleted genes result from the r18.
Case presentation: Here we describe a detailed diagnosis of a seven-year-old Chinese girl with a ring chromosome
18 mutation by a high-throughput whole-genome low-coverage sequencing approach without karyotyping and other
cytogenetic analysis. This method revealed two fragment heterozygous deletions of 18p and 18q, and further localized
the detailed breakpoint sites and fusion, as well as the deleted genes.
Conclusions: To our knowledge, this is the first report of a ring chromosome 18 patient in China analyzed by whole-
genome low-coverage sequencing approach. Detailed breakpoints location and deleted genes identification help to
estimate the risk of the disease in the future. The data and analysis here demonstrated the feasibility of next-generation
sequencing technologies for chromosome structure variation including ring chromosome in an efficient and cost
effective way.
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Ring chromosome 18 [r(18)] is formed from breakage of
both ends of the chromosome and the break ends generate
a ring chromosome [1]. Individuals with r(18) have 18p
and 18q partial deletions and according phenotype, such
as microcephaly, mental deficiency, hypotonia, and con-
genital heart defects [2, 3]. Short stature, microcephaly,
mental deficiency, craniofacial dysmorphism and extremity
abnormalities are the most commonly reported features in* Correspondence: @genomics.cn
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highly variable and depends on the combination of 18p-
syndrome and 18q- syndrome. Loss of critical genes on
each arm of chromosome 18 may contribute to the spe-
cific symptoms, and the clinical spectrum varieties may
heavily depend on the extent of the genomic deletion [4].
Whole-genome low-coverage sequencing has been
reported previously by our group to accurately detect
chromosomal structural variation-associated breakpoints
and affected region without cytogenetic analysis on pa-
tients [5].
In the current study, we applied whole-genome low-
coverage sequencing to characterize the ring chromosome
18 mutation at a molecular level in a Chinese young girlle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
Fig. 1 Abnormalities of the craniofacial appearance. Facial appearance of the patient at age 7, showing flat midface, puffy eyelids, hypertelorism,
epicanthic fold, flat nasal bridge, and micrognathia. a frontal view. b lateral view
Yao et al. BMC Medical Genetics  (2016) 17:49 Page 2 of 6for the first time. We described the full profile of clinical
examination, genetic characterizations, and clinical treat-
ment report. We localized the genomic breakpoints as
well as identified the deleted genes. The deletion of the
genes and detailed breakpoint identified help to under-
stand the genotype- correlation and estimate the risk of
the disease in the future.Case presentation
The patient was born to non-consanguineous at the year of
2006. The patient was born at 40 weeks gestation with a
birth weight of 3,050 g and length of 49 cm. At 2 years of
age, she was found shorter than children of the same age. In
April 2008, she was diagnosed hypothyroidism in the local
clinic. Replacement of thyroid hormone (levothyroxine) was
started for the treatment of autoimmune hypothyroidism.
Unregular treatment lasted one year and discontinue by par-
ents themselves.
At 6 and half years of age (March,2013), she came to our
hospital for short stature. At the time of our first evalu-
ation, she had a short stature problem (height: 90.7 cm
[−6.0SD, equivalently 50 percentile of 2–2.5 years old],
weight: 12.0 kg [<3 percentile, equivalently 50 percentile ofFig. 2 Pituitary gland on MRI. The MRI image results revealed that the Pituita
neurohypophysis was not seen clearly, which indicated pituitary dysplasia. a C2–2.5 years old]). The general examination phenotypes of
this patient include intellectual disability with IQ = 70,
hypoactive, poor appetite, hypotonia, short neck without
webbing, short fingers and toes, much shorter fifth fin-
ger, sparse hair and dry skin. She had dry stool once
every 1 ~ 3 days. No goiter, lymphadenopathy or hepa-
tosplenomegaly were noted.
The facial appearance of the patient was including flat
midface, puffy eyelids, hypertelorism, epicanthic fold, flat
nasal bridge, and micrognathia. Wide mouth, downturned
corners of mouth, thick lips, large protruding ears ptosis
and upslanting palpebral ptosis were also noted (Fig. 1).
High narrow palate and several cavities in teeth were ob-
served. In addition, she suffered from bronchitis and otitis
media frequently, without serious infections. Auscultation
revealed no heart murmur and normal respiratory sounds.
Serological examination results showed normal liver and
kidney functions but abnormal thyroid function, which
prompted central autoimmune hypothyroidism and auto-
immune thyroiditis. The thyroid auto antibodies were posi-
tive. Both TPO-Ab and TG-Ab were extremely high. The
levels of IGF-1 and IGF-BP3 decreased drastically. IgA was
slightly increased. E2、PROG、PRL and TESTO were all
normal (data not show). Flow cytometry detection of T cellry height was 1.0 mm, much smaller than the normal size, and the
oronal MRI scan of Pituitary Gland. b Sagittal MRI scan of Pituitary Gland
Fig. 3 Patient’s Karyotype analysis result by G-banding technique. The result of conventional karyotyping showed 46, XX, r(18) (arrow indicated)
Yao et al. BMC Medical Genetics  (2016) 17:49 Page 3 of 6subgroup revealed that CD3 and CD8 +T were slightly
higher (Additional file 1: Table S1). After euthyrox therapy,
her total cholesterol and the triglyceride were back to nor-
mal levels, but the lipoprotein-α was still high (494.2 mg/l,
reference range: 0-300 mg/l), the IGF-1 still low (29.8 ng/
ml, reference range:64-345 ng/ml).
The abdominal color ultrasound results showed normal
liver, uterus and ovaries. The sizes of both kidneys were
smaller than normal. (left kidney: 6.2 cm× 2.8 cm, right
kidney: 5.7 cm× 2.4 cm). The thyroid color ultrasound
revealed that the thyroid was enlarged and its echo was not
uniform. The thyroid isthmus was 0.5 cm thick (left lobe
thyroid: 2.9 cm× 1.0 cm× 1.2 cm, right lobe thyroid:
3.3 cm× 1.0 cm× 1.3 cm) accompanied with uneven in-
ternal spots and echoes, like a network. The cardiac color
ultrasound showed that the structure, shape and valves of
the heart had no obvious abnormality.
The MRI image results revealed that the Pituitary height
was 1.0 mm, much smaller than the normal size, and the
neurohypophysis was not seen clearly, which indicated
pituitary dysplasia (Fig. 2).Fig. 4 The Copy Number Ratio of Chromosome 18. The blue line indicates
Both ends of chromosome 18 has a partial deletion, the copy number ratio
from 150Kb to 180KbFollowing informed consent, hromosomal analysis was
performed on peripheral blood lymphocyte cultures. The re-
sult of conventional karyotyping was 46, XX, r (18) (Fig. 3).
No chromosomal anomaly was detected in either of parent
by karyotyping analysis (data not shown).
Patient’s genomic DNA was extracted from peripheral
blood using Qiagen DNA extraction kit and then was used
to construct DNA libraries and to do sequencing assay
including base calling. After removing reads containing
sequencing adaptors and low quality reads, the high quality
pair-end reads were aligned to the NCBI human reference
genome (hg19, GRCh37.1) using SOAP2 [6]. Only uniquely
mapped reads were remained in the following analysis.
The ring chromosome variation could be discovered
using chimeric read pairs, which are paired-end reads that
mapped to two different chromosomes.. The detail steps
are listed in our previous published study [5].
Finally, we identified two partial deletions which are a
portion of 18p from 1 bp to nearly 3,881,000 bp (3.88 Mb),
and a portion of 18q from nearly 73,239,191 bp to terminal
(4.83 Mb) base on the bioinformatics results. Both ends ofthe normal diploid copy number ratio, and the window size is 5 kb.
is 0.5 showed heterozygous terminal deficiency. Centromere starts









USP14 NM_001037334 chr18 158482 213739 +
NM_005151
THOC1 NM_005131 chr18 214519 268059 -
COLEC12 NM_130386 chr18 319354 500729 -
CETN1 NM_004066 chr18 580368 581524 +
NM_014410
NM_199167
C18orf56 NM_001012716 chr18 649619 658340 -
TYMS NM_001071 chr18 657603 673499 +
ENOSF1 NM_202758, chr18 670323 712517 -
NM_001126123
NM_017512
YES1 NM_005433 chr18 721591 812327 -
ADCYAP1 NM_001099733 chr18 904943 912173 +
NM_001117
METTL4 NM_022840 chr18 2537523 2571489 -
NDC80 NM_006101 chr18 2571509 2616634 +
SMCHD1 NM_015295 chr18 2655885 2805015 +
EMILIN2 NM_032048 chr18 2847027 2914090 +
LPIN2 NM_014646 chr18 2916991 3011945 -
MYOM1 NM_003803 chr18 3066804 3220106 -
NM_019856
MYL12A NM_006471 chr18 3247527 3256234 +
MYL12B NM_033546 chr18 3262110 3278282 +
NM_001144944
NM_001144945








DLGAP1 NM_001003809 chr18 3498836 3845296 -
NM_004746
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(Fig. 4). The remaining sequence of chromosome 18
generated a ring from breakage and subsequent fusion of
both chromosome arms. The two breakpoints located in
18p11.31 band and 18q23 band respectively. The detailed
breakpoint sites were validated to be at 3,880,565 bp and at
73,239,237 bp of chr18 respectively by Sanger sequencing.
Besides, we also found a 20 bp insertion between the fusion
breakpoints (Fig. 5). There were 19 genes deleted at
chromosome 18 (pter→ p11.31) and 12 genes deleted at
chromosome 18 (q23→ qter) (Tables 1 and 2).
Discussion
Ring chromosome 18 syndrome is a rare human cytogen-
etic abnormality. The syndrome is formed from breakage of
both ends of the chromosome and the break ends generate
a ring chromosome. The phenotype with r(18) syndrome is
highly variable and depends on the combination of 18p-
syndrome and 18q- syndrome [7]. The deletion of the short
arm of chromosome 18 became a well-known chromo-
somal aberration after first discovery by de Grouchy in
1963 [2]. In 2009, Patricia et al. analyzed 18q in a high reso-
lution level using aCGH, although they clarified the detailed
breakpoint location, the deleted genes result from breakage
of 18q were not able to be identified [8]. Normally, people
use conventional karyotyping, FISH or aCGH to analysis
chromosome aberrations, however, these methods have
their limitations of revealing responsible critical genes and
clarifying the genotype-phenotype correlations. Whole-
genome low-coverage sequencing analysis could solve these
problems at a base-level resolution.
Immunoglobulin A deficiency is frequently associated
with ring chromosome 18 syndrome [9]. However, IgA defi-
ciency was not noted in our patient, and further our patient
appears features of central autoimmune hypothyroidism
and small pituitary glands. The pituitary glands of our pa-
tient appeared morphologically small on head magnetic
resonance imaging, while the thyroid showed morphologic-
ally normal on ultrasound. After receiving 10 months
hormone therapy (levothyroxine), the IGF-1, T3 and T4
levels were still low, indicating that small pituitary invoked
some functional defects, which resulted in the negative
feedback failure of Hypothalamus-hypophysis-thyroid axis
(HHTA).
There were totally 31 genes deleted at the del(18p) and
del(18q) region. Some of them are very important for theFig. 5 The Sanger sequence alignment around the breakpoints of chromosome 18. We found there are a 20 bp insertion between the fusion breakpoints









ZNF516 NM_014643 chr18 74069636 74207146 -
NM_007345





GALR1 NM_001480 chr18 74962007 74982096 +
ATP9B NM_198531 chr18 76829396 77138282 +





CTDP1 NM_004715 chr18 77439800 77514510 +
NM_048368
NM_001202504
PQLC1 NM_001146343 chr18 77662419 77711653 -
NM_001146345
NM_025078
HSBP1L1 NM_001136180 chr18 77724581 77730822 +
TXNL4A NM_006701 chr18 77732866 77748532 -
RBFA NM_001171967 chr18 77794345 77810652 +
NM_024805
ADNP2 NM_014913 chr18 77866914 77898228 +
PARD6G NM_032510 chr18 77915116 78005397 -
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that encodes a member of the ubiquitin-specific processing
(UBP) family of proteases that is a deubiquitinating enzyme
(DUB). Mice with a mutation that results in reduced ex-
pression of the ortholog of this protein are retarded for
growth [10]. Gripp et al. [11] concluded that TGIF1 links
the NODAL signaling pathway to the bifurcation of the
human forebrain and the establishment of ventral midline
structures. The GALR1 gene is widely expressed in the
brain and spinal cord, as well as in peripheral sites such as
the small intestine and heart [12]. Mutations in CTDP1
gene are associated with congenital cataracts, facial dys-
morphism and neuropathy syndrome (CCFDN) [13]. So
that, the inactivity of these genes may results to neurodeve-
lopment, craniofacial appearance, oral manifestations and
brain development anomalies.
In this report, We have presented a ring chromosome 18
patient with two heterozygous deletions of 3.88 Mb and
4.83 Mb indentified by whole-genome low-coveragesequencing method. The deletion of the genes and ring
closure of chromosome 18 contribute to the clinical picture
of dysmorphogenesis and mental retardation. Detailed
breakpoints location and deleted genes identification help
to estimate the risk of the disease in the future. At the same
time, further studies are needed to delineate the function of
responsible critical genes and clarify the genotype-
phenotype correlations. The report here demonstrated the
feasibility of next-generation sequencing technologies for
chromosomal structural variation including ring chromo-
some in an efficient and cost effective way, which would
improve the detection and prediction of genotype and
phenotypic outcomes to direct postnatal medical care.
Conclusions
In conclusion, we analyzed a ring chromosome 18 patient
in China by whole-genome low-coverage sequencing
method for the first time. We described the full profile of
clinical examination, genetic characterizations, and clinical
treatment report. We localized the genomic breakpoints
as well as identified the deleted genes. Detailed break-
points location and deleted genes identification help to
estimate the risk of the disease in the future. The report
here demonstrated the feasibility of next-generation se-
quencing technologies for chromosomal structural vari-
ation including ring chromosome in an efficient and cost
effective way, which would improve the detection and pre-
diction of genotype and phenotypic outcomes to direct
postnatal medical care.
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